Medical Specialties

Chronic Total Occlusion Market to 2025 – Global Analysis By Boston Scientific Corporation, Medtronic, Terumo Corporation, Cordis, Abbott

The global chronic total occlusion market accounted to US$ 280.7 Mn in 2017 and is expected to grow at a CAGR of 8.1% during the forecast period 2018 – 2025, to account to US$ 516.1 Mn by 2025.

North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period. North American market is driven due to the high prevalence of coronary artery disease and peripheral artery.

Request Exclusive Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPMD00002711/

Since the last 25 years, the number of cardiovascular cases has increased in Europe and in the European Union. The addition in the cardiovascular cases are observed in most of the countries in this region. According to the European Cardiovascular Disease Statics in 2015, near about 85 million people in Europe and 49 million in EU were suffering with cardiovascular diseases. In Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the major reason of the death in men and women in all countries.

Major vendors covered in this report:

ASAHI INTECC CO., LTD.
SoundBite Medical Solutions
Integer Holdings Corporation
Baylis Medical Company, Inc.
SPECTRANETICS
C. R. Bard, Inc.
Boston Scientific Corporation
Medtronic
Terumo Corporation
Cordis
Abbott

Advancement in the field of science has enhanced the chronic total occlusion devices. Many industry players have come up with innovative types of chronic total occlusion devices in last few years. The advancement in the chronic total occlusion devices has led to the faster and easier treatment and recovery of patients. For instance, in September 2018, SoundBite Medical Solutions Inc. (SBMS) launched the ACTIVE Trial, recently approved study by Health Canada for the demonstration of the potential of the SoundBite Active Wire to cross coronary chronic total occlusions (CTOs). Moreover, in February 2018, Asahi Intecc received the FDA approval for CTO (Chronic Total Occlusion) indication for selected products. The approval aims to provide help to the cardiologists to successfully complete complex procedures that now account for up to 70 percent of cases.

Advancement in the field of science has enhanced the chronic total occlusion devices. Many industry players have come up with innovative types of chronic total occlusion devices in last few years. The advancement in the chronic total occlusion devices has led to the faster and easier treatment and recovery of patients. For instance, in September 2018, SoundBite Medical Solutions Inc. (SBMS) launched the ACTIVE Trial, recently approved study by Health Canada for the demonstration of the potential of the SoundBite Active Wire to cross coronary chronic total occlusions (CTOs). Moreover, in February 2018, Asahi Intecc received the FDA approval for CTO (Chronic Total Occlusion) indication for selected products. The approval aims to provide help to the cardiologists to successfully complete complex procedures that now account for up to 70 percent of cases.

Strategic Insights

Acquisitions and approvals were observed as the most adopted strategy in global chronic total occlusion industry. Few of the acquisitions and approvals made by the players in the market are listed below:

2018: In April, 2018, Asahi Intecc Co., Ltd received CTO indication from US FDA for its PTCA guidewires: ASAHI Gaia series, MIRACLEBROS/ASAHI Miracle series, CONFIANZA/Conquest series, FIELDER XT, FIELDER XT-A, FIELDER XT-R, ULTIMATEbros 3 and Microcatheters: ASAHI Corsair, Corsair Pro microcatheters.

2017: In August, 2017, Koninklijke Philips N.V. acquired The Spectranetics Corporation. This acquisition will accelerate Philip’s strategic expansion into therapy devices.

Following Key points(Analysis) is covered In this Report.

Chronic Total Occlusion Market Revenue, Price Analysis.
Market Size and Price Analysis, ROI, & PEST analysis, SWOT Analysis.
Chronic Total Occlusion Industry Positioning in the Market, Opportunities, market risk, market driving force.
Mainly focuses industry Chronic Total Occlusion market profiles and market share.
Analysis Of Chronic Total Occlusion market trends during the forecast period from 2020 to 2026.
Provides Market Shares, Market Distributors and traders, facts and figures Of Current Chronic Total Occlusion market.
Describes Production and revenue by Region considering sales, market size, revenue, growth rate, price, and trends

Checkout Inquiry For Buying or Customization of Report: https://www.theinsightpartners.com/buy/TIPMD00002711/

Thanks for reading this article; you can also customize this report to get select chapters or region-wise coverage with regions such as Asia, North America, and Europe.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.